Growth Metrics

Alector (ALEC) EBIT Margin (2018 - 2026)

Alector (ALEC) reported EBIT Margin of 2382.31% for Q1 2026, down 116579.0% year-over-year from N/an in Q1 2025, and down 271.85% on a QoQ basis from 1386.26% in Q4 2025.

Alector (ALEC) has 9 years of EBIT Margin data on file, last reported at 2382.31% in Q1 2026.

  • Quarterly EBIT Margin fell 116579.0% year-over-year to 2382.31% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 55.41% (up 10985.0% YoY) and the FY2025 annual result came in at 142.46%, up 174.0% from the prior year.
  • EBIT Margin eased to 2382.31% in Q1 2026 per ALEC's latest filing, from 1386.26% in the prior quarter.
  • Across five years, EBIT Margin topped out at 1386.26% in Q4 2025 and bottomed at 2382.31% in Q1 2026.
  • The 5-year median for EBIT Margin is 302.83% (2023), against an average of 348.85%.
  • The widest annual swing landed in 2025, when EBIT Margin soared 139962 bps; it then plunged 116579 bps in 2026.
  • Tracing ALEC's EBIT Margin over 5 years: stood at 383.92% in 2022, then surged by 234 bps to 514.15% in 2023, then tumbled by 103 bps to 13.36% in 2024, then soared by 10473 bps to 1386.26% in 2025, then tumbled by 272 bps to 2382.31% in 2026.
  • Per Business Quant, the three latest ALEC EBIT Margin figures stand at 2382.31% (Q1 2026), 1386.26% (Q4 2025), and 1153.62% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 23.02%
10 Alector 238.87 Mn 32.36 Mn - -2,382.31%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,382.31%
Dec 31, 2025 1,386.26%
Sep 30, 2025 -1,153.62%
Jun 30, 2025 -433.55%
Mar 31, 2025 -1,216.52%
Dec 31, 2024 -13.36%
Sep 30, 2024 -315.70%
Jun 30, 2024 -302.37%
Mar 31, 2024 -275.01%
Dec 31, 2023 514.15%
Sep 30, 2023 -555.31%
Jun 30, 2023 -6.38%
Mar 31, 2023 -302.83%
Dec 31, 2022 -383.92%
Sep 30, 2022 -321.49%
Jun 30, 2022 11.87%
Mar 31, 2022 -180.29%
Dec 31, 2021 -185.77%
Sep 30, 2021 69.25%
Jun 30, 2021 -842.34%
Mar 31, 2021 -1,280.66%
Dec 31, 2020 2,111.44%
Sep 30, 2020 -910.38%
Jun 30, 2020 -1,469.68%
Mar 31, 2020 -586.78%
Dec 31, 2019 -538.94%
Sep 30, 2019 -1,266.65%
Jun 30, 2019 -392.54%
Mar 31, 2019 -370.40%
Dec 31, 2018 -207.95%
Sep 30, 2018 -258.57%
Jun 30, 2018 -172.05%
Mar 31, 2018 -187.50%